XML 35 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Assumptions that Used to Determine Grant-Date Fair Value of Stock Options Granted to Employees and Members of Board

The assumptions that the Company used to determine the grant-date fair value of stock options granted to employees and members of the Board were as follows, presented on a weighted-average basis:

 

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

Expected option life (years)

 

 

5.97

 

 

 

6.05

 

Risk-free interest rate

 

 

2.40

%

 

 

2.73

%

Expected volatility

 

 

81.25

%

 

 

83.42

%

Expected dividend yield

 

 

%

 

 

%

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2019:

 

 

 

Number of

Options

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding as of December 31, 2018

 

 

2,164,100

 

 

$

7.75

 

 

 

8.77

 

 

$

23,083

 

Granted

 

 

1,315,317

 

 

$

16.76

 

 

 

 

 

 

 

 

 

Exercised

 

 

(232,758

)

 

$

2.14

 

 

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(101,231

)

 

$

10.26

 

 

 

 

 

 

 

 

 

Outstanding as of September 30, 2019

 

 

3,145,428

 

 

$

11.86

 

 

 

8.63

 

 

$

15,491

 

Exercisable as of September 30, 2019

 

 

790,343

 

 

$

3.99

 

 

 

7.51

 

 

$

8,759

 

Vested and expected to vest as of September 30, 2019

 

 

3,145,428

 

 

$

11.86

 

 

 

8.63

 

 

$

15,491

 

Summary of Restricted Stock Unit Activity

The following table summarizes the Company’s restricted common stock activity for the nine months ended September 30, 2019:

 

 

 

Number

of Shares

 

 

Weighted-

Average

Grant

Date Fair

Value

 

Issued and unvested as of December 31, 2018

 

 

153,275

 

 

$

0.42

 

Granted

 

 

2,300

 

 

$

15.65

 

Vested

 

 

(92,262

)

 

$

0.42

 

Forfeited, canceled or expired

 

 

 

 

$

 

Issued and unvested as of September 30, 2019

 

 

63,313

 

 

$

0.42

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense was allocated as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Research and development

 

$

889

 

 

$

230

 

 

$

2,649

 

 

$

417

 

General and administrative

 

 

908

 

 

 

320

 

 

 

2,265

 

 

 

700

 

Total stock-based compensation expense

 

$

1,797

 

 

$

550

 

 

$

4,914

 

 

$

1,117